A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.

Edward E WalshAnn R FalseyDaniel A ScottAlejandra GurtmanAgnieszka M ZarebaKathrin U JansenWilliam C GruberPhilip R DormitzerKena A SwansonDavid RadleyEmily GommeDavid CooperBeate Schmoele-Thoma

Published in: The Journal of infectious diseases (2022)

NCT03529773.

Keyphrases

respiratory syncytial virus
open label
double blind
placebo controlled
randomized controlled trial
study protocol